PKP triple procedure with a 25G is a safe treatment option

Article

Penetrating keratoplasty (PKP) triple procedures with a 25G system is a safe and effective treatment option.

Penetrating keratoplasty (PKP) triple procedures with a 25G system is a safe and effective treatment option, claims a study in the journal Cornea.

Dr Shiro Higaki et al., Department of Ophthalmology, Kinki University Faculty of Medicine, Osaka-Sayama, Japan, divided 30 patients into three groups. The groups were 12 eyes of 12 patients in the PKP group that underwent 25G vitrectomy, 9 eyes and 9 patients that underwent 20G vitrectomy and 9 eyes of 9 patients in the non-core vitrectomy group who underwent PKP without core vitrectomy.

The success rates of the IOL implantation were 97.1%, 88.9% and 66.7% for the 25G, 20G, and non-core vitrectomy groups, respectively. At 69 minutes for an average operation time the 25G group demonstrated the shortest time, compared to 82 minutes, and 90 minutes in the 20G group and the non-core vitrectomy group, respectively.

The PKP triple procedure with the 25G system offers a higher success rate of IOL implantation and significantly reduced operation time compared to 20G and non-core vitrectomy.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.